It is now obvious that large samples are essential to make much headway on the genetics of schizophrenia (SCZ). To identify genes that underlie liability to SCZ, we will recruit a large and diverse sample of 1260 African- American families, primarily from the southeastern US, all of whom have at least one member diagnosed with SCZ. A substantial portion of this diverse set of families will contribute to standard Affected Sibling and Relative Pair linkage analysis and to Quantitative Trait Locus (QTL) analyses of neurocognitive traits; the entire sample will be used for admixture mapping in candidate regions of interest This project also lays the foundation for QTL analysis by examining genetic influences on cognitive abilities among persons affected by SCZ and their extended family members. This minority sample would be impossible to recruit without multiple participating sites using the same protocol. Eight institutional sites have teamed up under the Collaborative ROls for Clinical Studies of Mental Disorders to accomplish this goal. The collaboration marries expertise in diagnoses, neurocognitive assessments, family recruitment, and genetic analyses. Substantial samples and refined, multivariate phenotypes should combine to give unprecedented power to determine susceptibility genes for this disease. Our study design is motivated by several considerations. The time is ripe for merging finer phenotypic information with rigorous diagnosis, and the analytic tools are in place, both for finer phenotypic characterization and the joint analysis of phenotypes and genotypes. In terms of mental health, African Americans are an underserved population. The genetic basis of SCZ in the African-American population must have its roots in both Africa and Europe. if the liability alleles for SCZ were different on the two continents, either in kind or frequency, then what we learn from the study of peoples of European ancestry will not necessarily transfer seamlessly to the African population and, by extension, to the African-American population. Therefore it is essential to study SCZ genetics in African-American populations. Finally, we have an outstanding track record of African American participation in research studies, and a deep appreciation of their population genetics.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
1R01MH066004-01
Application #
6506484
Study Section
Special Emphasis Panel (ZRG1-MGN (02))
Program Officer
Moldin, Steven Owen
Project Start
2002-09-18
Project End
2007-07-31
Budget Start
2002-09-18
Budget End
2003-07-31
Support Year
1
Fiscal Year
2002
Total Cost
$633,181
Indirect Cost
Name
Medical University of South Carolina
Department
Psychiatry
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Watson, A M M; Prasad, K M; Klei, L et al. (2013) Persistent infection with neurotropic herpes viruses and cognitive impairment. Psychol Med 43:1023-31
Wiener, Howard; Klei, Lambertus; Calkins, Monica et al. (2013) Principal components of heritability from neurocognitive domains differ between families with schizophrenia and control subjects. Schizophr Bull 39:464-71
Da Silva, Felipe N; Irani, Farzin; Richard, Jan et al. (2012) More than just tapping: index finger-tapping measures procedural learning in schizophrenia. Schizophr Res 137:234-40
Bamne, Mikhil; Wood, Joel; Chowdari, Kodavali et al. (2012) Evaluation of HLA polymorphisms in relation to schizophrenia risk and infectious exposure. Schizophr Bull 38:1149-54
Savage, R M; Wiener, H W; Nimgaonkar, V et al. (2012) Heritability of functioning in families with schizophrenia in relation to neurocognition. Schizophr Res 139:105-9
Irani, Farzin; Brensinger, Colleen M; Richard, Jan et al. (2012) Computerized neurocognitive test performance in schizophrenia: a lifespan analysis. Am J Geriatr Psychiatry 20:41-52
Calkins, Monica E; Tepper, Ping; Gur, Ruben C et al. (2010) Project among African-Americans to explore risks for schizophrenia (PAARTNERS): evidence for impairment and heritability of neurocognitive functioning in families of schizophrenia patients. Am J Psychiatry 167:459-72
Talkowski, Michael E; McClain, Lora; Allen, Trina et al. (2009) Convergent patterns of association between phenylalanine hydroxylase variants and schizophrenia in four independent samples. Am J Med Genet B Neuropsychiatr Genet 150B:560-9
Irvin, M R; Wiener, H W; Perry, R P et al. (2009) Genetic risk factors for type 2 diabetes with pharmacologic intervention in African-American patients with schizophrenia or schizoaffective disorder. Schizophr Res 114:50-6
Wiener, H W; Klei, L; Irvin, M D et al. (2009) Linkage analysis of schizophrenia in African-American families. Schizophr Res 109:70-9

Showing the most recent 10 out of 12 publications